Letrozole tablets 2.5 mg “Meiji” by Meiji Seika Pharma contains Letrozole, an aromatase inhibitor primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. Each tablet contains 2.5 mg, and the YJ code is 4291015F1182.
Letrozole tablets 2.5 mg “Meiji”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
